Both in Pharmaceuticals
Aptevo Therapeutics vs Mustang Bio
Over the past year APVO returned −94.9% and MBIO returned −70.5%; their daily moves had a correlation of 0.13.
APVO −94.9% MBIO −70.5%Growth of $1, one year, split-adjusted
| Metric | APVO | MBIO |
|---|---|---|
| Price | $1.36 | $0.4094 |
| Market cap | $2.5M | $3.1M |
| Today | +0.74% | −1.35% |
| 1 month | −24.4% | −11.0% |
| 6 months | −74.6% | −47.1% |
| Year to date | −85.6% | −58.3% |
| 1 year | −95.1% | −71.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.8M | $15.2M |
| Dividend yield | — | — |
| Volatility (60d) | 112.7% | 50.0% |
| Short % of float | 5.8% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).